Market Access France ‘first EU country to cover obesity drugs’ PharmaphorumFrance's Health Minister has said that the country is the first in the EU to provide reimbursement coverage for GLP-1 weight-loss therapies.Metabolic & GLP-1Read full story pharminent May 28, 2026 (Last updated: May 29, 2026) Pharmaphorum France’s Health Minister has said that the country is the first in the EU to provide reimbursement coverage for GLP-1 weight-loss therapies. Metabolic & GLP-1 Read full story Post navigation Previous: GSK hails ‘unprecedented’ cure rates with hep B drugNext: CVS obesity drug deal puts Lilly on equal footing with Novo Related Stories Market Access How cost and perception could reshape the GLP-1 market pharminent August 21, 2026 Market Access D.C. Circuit Affirms HHS Authority Over 340B Rebate Models pharminent July 24, 2026 Market Access NICE aims to cut funding for Amgen lung cancer drug Lumykras pharminent July 9, 2026
